Citigroup’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $769K | Sell |
31,375
-10,645
| -25% | -$252K | ﹤0.01% | 3284 |
|
|
2025
Q4 | $1.04M | Sell |
42,020
-4,860
| -10% | -$129K | ﹤0.01% | 3113 |
|
|
2025
Q3 | $1.33M | Sell |
46,880
-9,982
| -18% | -$271K | ﹤0.01% | 2977 |
|
|
2025
Q2 | $1.41M | Sell |
56,862
-7,426
| -12% | -$209K | ﹤0.01% | 2948 |
|
|
2025
Q1 | $1.99M | Buy |
64,288
+4,113
| +7% | +$137K | ﹤0.01% | 2712 |
|
|
2024
Q4 | $1.9M | Buy |
60,175
+4,369
| +8% | +$208K | ﹤0.01% | 2867 |
|
|
2024
Q3 | $3.23M | Buy |
55,806
+20,970
| +60% | +$1.03M | ﹤0.01% | 2237 |
|
|
2024
Q2 | $1.41M | Sell |
34,836
-27,834
| -44% | -$1.1M | ﹤0.01% | 2632 |
|
|
2024
Q1 | $2.63M | Buy |
62,670
+37,696
| +151% | +$1.47M | ﹤0.01% | 2210 |
|
|
2023
Q4 | $957K | Buy |
24,974
+8,099
| +48% | +$270K | ﹤0.01% | 2856 |
|
|
2023
Q3 | $521K | Sell |
16,875
-13,444
| -44% | -$464K | ﹤0.01% | 3036 |
|
|
2023
Q2 | $958K | Buy |
30,319
+11,761
| +63% | +$403K | ﹤0.01% | 2873 |
|
|
2023
Q1 | $677K | Sell |
18,558
-7,558
| -29% | -$265K | ﹤0.01% | 2883 |
|
|
2022
Q4 | $773K | Buy |
26,116
+7,479
| +40% | +$240K | ﹤0.01% | 2854 |
|
|
2022
Q3 | $727K | Buy |
18,637
+1,701
| +10% | +$77.9K | ﹤0.01% | 2962 |
|
|
2022
Q2 | $654K | Sell |
16,936
-15,793
| -48% | -$601K | ﹤0.01% | 3023 |
|
|
2022
Q1 | $1.59M | Buy |
32,729
+3,734
| +13% | +$193K | ﹤0.01% | 2546 |
|
|
2021
Q4 | $2.13M | Sell |
28,995
-3,740
| -11% | -$307K | ﹤0.01% | 2573 |
|
|
2021
Q3 | $2.98M | Buy |
32,735
+23,564
| +257% | +$2M | ﹤0.01% | 2206 |
|
|
2021
Q2 | $576K | Buy |
9,171
+7,521
| +456% | +$278K | ﹤0.01% | 3605 |
|
|
2021
Q1 | $45K | Sell |
1,650
-2,960
| -64% | -$71.2K | ﹤0.01% | 4760 |
|
|
2020
Q4 | $84K | Buy |
4,610
+3,354
| +267% | +$60.3K | ﹤0.01% | 5674 |
|
|
2020
Q3 | $23K | Sell |
1,256
-5,128
| -80% | -$88.5K | ﹤0.01% | 6104 |
|
|
2020
Q2 | $105K | Buy |
6,384
+4,823
| +309% | +$75.9K | ﹤0.01% | 5533 |
|
|
2020
Q1 | $20K | Sell |
1,561
-498
| -24% | -$8.13K | ﹤0.01% | 6702 |
|
|
2019
Q4 | $38K | Buy |
2,059
+703
| +52% | +$11.7K | ﹤0.01% | 6542 |
|
|
2019
Q3 | $24K | Sell |
1,356
-387
| -22% | -$6.62K | ﹤0.01% | 6631 |
|
|
2019
Q2 | $30K | Buy |
1,743
+848
| +95% | +$15.4K | ﹤0.01% | 6874 |
|
|
2019
Q1 | $17K | Sell |
895
-83
| -8% | -$1.59K | ﹤0.01% | 7044 |
|
|
2018
Q4 | $19K | Sell |
978
-528
| -35% | -$9.88K | ﹤0.01% | 6911 |
|
|
2018
Q3 | $33K | Sell |
1,506
-2,051
| -58% | -$43.2K | ﹤0.01% | 6838 |
|
|
2018
Q2 | $92K | Buy |
3,557
+2,557
| +256% | +$43.8K | ﹤0.01% | 5808 |
|
|
2018
Q1 | $16K | Buy |
+1,000
| New | +$20.7K | ﹤0.01% | 6863 |
|
Other funds holding ASTH
VPM
3C
VCM
6CM
Citigroup's ASTH Position: Q1 2026 in Review
Citigroup reduced its Astrana Health (ASTH) stake by 25% in Q1 2026, selling an estimated $252K and leaving 31,375 shares worth $769K. The position accounts for ﹤0.01% of the portfolio, ranked #3284.
Citigroup first reported a position in ASTH in Q1 2018 and has held it in 33 quarters since. The position peaked at $3.23M in Q3 2024. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.
- Citigroup held 31,375 shares of Astrana Health worth $769K as of Q1 2026.
- Citigroup sold 10,645 Astrana Health shares in Q1 2026, an estimated $252K.
- Astrana Health made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3284 holding.
- Citigroup first reported a position in Astrana Health in Q1 2018 and has held it in 33 quarters since.
- Citigroup's Astrana Health position peaked at $3.23M in Q3 2024.
- 171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.